Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Use of TpCO2 (Transcutaneous CO2 Measurement) as PaCO2 Predictor During NIV in Case of Acute Hypercapnic Respiratory Failure (TpCO2-NIV)

This study has been completed.
Information provided by (Responsible Party):
Prof. Philippe Jolliet, University of Lausanne Hospitals Identifier:
First received: May 15, 2013
Last updated: June 7, 2015
Last verified: June 2015
In patients suffering from hypercapnic respiratory failure and treated by non invasive ventilation (NIV), the interest of using transcutaneous CO2 measurement to evaluate PaCO2 and PaCO2 variation over time is unknown and will be evaluated in this study. Measurements will be done during one-hour NIV treatments.

Hypercapnic Respiratory Failure

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Use of TpCO2 (Transcutaneous CO2 Measurement)as PaCO2 Predictor During Non Invasive Ventilation (NIV) in Case of Acute Hypercapnic Respiratory Failure

Resource links provided by NLM:

Further study details as provided by University of Lausanne Hospitals:

Primary Outcome Measures:
  • Comparison between TpCO2 (transcutaneous non invasive CO2 partial pressure measurement) and PaCO2 (obtained by blood gas analysis) values during NIV treatment. [ Time Frame: sixty minutes ]

Enrollment: 20
Study Start Date: February 2013
Study Completion Date: March 2015
Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Intensive care unit patients equipped with an arterial line and requiring non invasive ventilation because of acute hypercapnic respiratory failure

Inclusion Criteria:

  • ICU patient equipped with an arterial line
  • NIV treatment prescribed by the clinician in charge
  • Hypercapnia defined by PaCO2> 42mmHg

Exclusion Criteria:

  • Severe hemodynamic instability
  • Severe psychiatric disorders
  • Denied consent
  • Age < 18 years
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01857635

Intensive care and burn unit, University hospital of Lausanne
Lausanne, Switzerland, 1011
Sponsors and Collaborators
University of Lausanne Hospitals
Principal Investigator: Philippe Jolliet, Prof University of Lausanne Hospitals
  More Information

Responsible Party: Prof. Philippe Jolliet, Principal investigator, University of Lausanne Hospitals Identifier: NCT01857635     History of Changes
Other Study ID Numbers: TpCO2-NIV
Study First Received: May 15, 2013
Last Updated: June 7, 2015

Keywords provided by University of Lausanne Hospitals:
Acute respiratory failure
Non invasive ventilation
Transcutaneous CO2 measurement

Additional relevant MeSH terms:
Respiratory Insufficiency
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms processed this record on May 24, 2017